Contacts
Every person and organization shaping the peptide landscape — researchers publishing the science, clinicians applying it, influencers amplifying it, and pharma companies bringing it to market.
Podcasters, biohackers, and content creators shaping the peptide conversation
Scientists and academics publishing the foundational peptide science
Physicians and practitioners working with peptide therapy
Companies developing and manufacturing FDA-approved peptide-based drugs
18 results
Predrag Sikiric is a researcher focusing on the therapeutic applications of peptides, particularly BPC-157.
Allan L. Goldstein is an American molecular biologist known for his research on thymosin alpha-1 and thymosin beta-4, focusing on their roles in various biological processes including immunology, neurogenesis, and tissue repair.
Ana Maria Cuervo is a Spanish-American physician and researcher specializing in cell biology at the Albert Einstein College of Medicine, where she investigates autophagy's role in aging and age-related diseases.
Brian K. Kennedy is an American biologist known for his research on aging and metabolism, including studies on NAD+ and interventions to slow aging in humans.
Cyril Y. Bowers, M.D., is an emeritus professor of medicine at Tulane University with extensive research in endocrinology and metabolism, focusing on growth hormone regulation and the effects of sex steroids.
David M. Sabatini is an American cell biologist known for his work on the mTOR pathway and its regulation by nutrients, contributing significantly to the understanding of cellular metabolism and aging.
Johan Auwerx is a Belgian biologist and professor at EPFL, focusing on cellular metabolism and mitochondrial function.
Kent Holtorf is an American physician and entrepreneur based in Los Angeles, founder of the Holtorf Medical Group which offers treatments for various conditions using alternative therapies. He is known for his work on hormone therapy and peptide-based treatments.
Loren Cordain is an American scientist specializing in nutrition and exercise physiology, known for advocating the Paleolithic diet.
Michael Chorev is a researcher focusing on peptide chemistry, particularly the design and synthesis of novel peptide analogues. His work includes conformational analysis and biological activity studies of these compounds.
Michael Zasloff is an immunologist and biotechnology entrepreneur known for discovering antimicrobial peptides in amphibians, including magainins, and developing shark-derived compound squalamine. He is currently a professor at Georgetown University School of Medicine and Scientific Director of the MedStar Georgetown Transplant Institute.
Nir Barzilai is an Israeli geneticist and longevity researcher known for his work on the genetics of human longevity and the role of insulin-like growth factor 1 (IGF-1) in aging.
Richard DiMarchi is an American pharmaceutical chemist and professor at Indiana University, known for his research on GLP-1 and semaglutide. He previously served as a vice president at Eli Lilly and Company.
Svetlana Morozova is a researcher with expertise in the persistence length of α-helical poly-L-lysine. She has published work relevant to the peptide field, particularly focusing on semax and selank.
Victor Hruby is a researcher known for his work in peptide chemistry, including the development of melanotan and PT-141.
Vladimir Khavinson was a Russian gerontologist and professor known for his research on peptide bioregulators, including epithalon.
William Mitch is a researcher focusing on peptide therapy and its implications in longevity, muscle health, and chronic diseases such as kidney disease and diabetes.